Latest California Healthline Stories
Many states are dramatically loosening regulations on nurse practitioners as the coronavirus pandemic increases demand for health care workers. But not California.
Wisconsin hospitals had filed at least 104 lawsuits in small claims court since the state declared a public health emergency March 12. Most now say they are suspending the cases; one hospital has dismissed them after a reporter’s calls.
For rural physicians, the burden of responding to the opioid epidemic falls squarely on their already loaded shoulders. For one doctor in a small Wisconsin village, there was no question that she wanted to rise to the challenge.
Without the teamwork, communication and quick action of several veteran health officials in Wisconsin, the world might not know about the vaping illness the U.S. is battling today. This is their story.
Some Veterans Affairs hospitals around the country use writers to record patients’ life stories, then place a short biography in each vet’s medical record. The My Life, My Story program gives clinicians another way to get to know their patients.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News and Joanne Kenen of Politico discuss the start of open enrollment for individual health insurance plans for 2019 and preview what next week’s midterm elections might mean for health policy. Plus, Barbara Feder Ostrov of KHN and California Healthline talks to Julie about the latest NPR-KHN “Bill of the Month” feature.
The Group Insurance Board reversed a decision made last year to bar coverage of transgender hormone therapy and surgery for public workers.
Dramatic policy swings, from an unprecedented expansion of transgender rights under the Obama administration to the unpredictable reduction of trans rights under President Donald Trump, have left many trans Americans feeling the whiplash.
Moly-99, as it’s called, is created in just six government-owned nuclear research reactors — none in North America — raising concerns about the reliability of the supply.
The Trump administration is poised to grant states waivers that some critics say could change the shape of the program.